D'Haese, Jan G <br/><br/>
Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Feb 2010 
 - 207-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1517/14728220903540265  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Chemokine CX3CL1--antagonists & inhibitors<br/>Humans<br/>Inflammation--etiology<br/>Neoplasms--drug therapy<br/>Pain--drug therapy<br/>Pancreatic Diseases--drug therapy